GlassScriptPhysician profile
Emily Herman
NPI 1033818505
$744.64
in general payments reported to CMS, 2019-2025
14 companies · $318 in 2025
The $318 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $195 · 2024: $232 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $731 · Education: $13.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $731.04 |
| Education | $13.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $156.11 | 2023-2024 | |
| Amgen INC. | $147.31 | 2024-2025 | Tavneos |
| Travere Therapeutics, INC. | $108.52 | 2025 | Filspari |
| Novartis Pharmaceuticals Corporation | $66.15 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $52.80 | 2023-2024 | Farxiga, Lokelma |
| Aurinia Pharma U.S., INC. | $43.26 | 2024 | Lupkynis |
| Opko Pharmaceuticals, LLC | $38.90 | 2024 | Rayaldee |
| Otsuka America Pharmaceutical, INC. | $31.10 | 2023 | Jynarque |
| Abbvie INC. | $20.72 | 2025 | |
| Novo Nordisk INC | $18.15 | 2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $16.40 | 2025 | Bexsero |
| Silk Road Medical, INC. | $16.28 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Boston Scientific Corporation | $15.34 | 2023 | Watchman Flx |
| Calliditas Therapeutics US INC. | $13.60 | 2023 | Tarpeyo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Herman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.